 | |
| Clinical data | |
|---|---|
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C18H18Cl2N2O2 |
| Molar mass | 365.25 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Tolgabide (INN; development codeSL-81.0142) is adrug which was patented bySynthélabo as ananticonvulsant but was never marketed.[1] It is ananalogue ofprogabide and acts similarly to it as aprodrug ofGABA, and therefore as an indirectagonist of theGABA receptors.[1][2]